Showing results (411-420 of 563) with videos related to
Sort By:
Pageof 57
Journal of Vascular Surgery|September 13, 2011
Development of the Australasian vascular surgical auditBernie M Bourke, Charles Barry Beiles, Ian A Thomson, et al.Eye (London, England)|July 23, 2013
The impact of the Virtual Ophthalmology Clinic on medical students' learning: a randomised controlled trialT Succar, G Zebington, F Billson, et al.The Journal of Pediatrics|April 1, 1993
Bilateral fiberoptic bronchoalveolar lavage in acute unilateral lobar pneumoniaJ Grigg, C van den Borre, A Malfroot, et al.The American Review of Respiratory Disease|November 1, 1993
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitisM Linden, J B Rasmussen, E Piitulainen, et al.The Journal of Allergy and Clinical Immunology|February 15, 2001
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' durationK Amin, J Rinne, T Haahtela, et al.Heart (British Cardiac Society)|July 16, 2005
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery diseaseB Lagerqvist, E Diderholm, B Lindahl, et al.Journal of the American College of Cardiology|March 18, 1999
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II)G Frostfeldt, G Ahlberg, G Gustafsson, et al.The Journal of Allergy and Clinical Immunology|October 1, 1991
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthmaJ Bousquet, P Chanez, J Y Lacoste, et al.The European Respiratory Journal|October 1, 1988
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variablesA Eklund, O Eriksson, L Håkansson, et al.British Journal of Haematology|September 13, 2001
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's diseaseD Molin, M Fischer, Z Xiang, et al.Pageof 57